Stockscreener 앱 받기
0.5903
4.30%
-0.0265
전일 마감가:
$0.6168
열려 있는:
$0.6
하루 거래량:
35,870
Relative Volume:
0.05
시가총액:
$8.07M
수익:
-
순이익/손실:
$-39.62M
주가수익비율:
-0.000357
EPS:
-1654.3275
순현금흐름:
$-17.96M
1주 성능:
-35.14%
1개월 성능:
-82.74%
6개월 성능:
-99.66%
1년 성능:
-99.95%
1일 변동 폭
$0.5801
$0.6167
1주일 범위
$0.5801
$0.8855
52주 변동 폭
$0.5801
$2,360.00
Cdt Equity Inc Stock (CDT) Company Profile
명칭
Cdt Equity Inc
전화
(646) 491 9132
주소
4851 TAMIAMI TRAIL NORTH, NAPLES
Compare CDT vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CDT
Cdt Equity Inc
|
0.5892 | 8.45M | 0 | -39.62M | -17.96M | -1,654.33 |
VRTX
Vertex Pharmaceuticals Inc
|
521.80 | 134.06B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
799.80 | 83.43B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
997.54 | 63.00B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
138.63 | 56.02B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.09 | 44.44B | 742.00K | -1.37B | -1.07B | -7.0731 |
Cdt Equity Inc 주식(CDT)의 최신 뉴스
CDTG Stock Jumps After Sharp Intraday Reversal - timothysykes.com
CDTG Stock Jumps After Volatile Intraday Spike - StocksToTrade
CDT Equity Amends Sarborg Deal, Manages Convertible Financing - TipRanks
CDT Equity Amends $8 Million Sarborg Investment and Adds $542K Convertible Note, Later Repaid - TradingView
CDT Equity Inc. announced that it has received $1.46 million in funding from J.J. Astor & Co. - marketscreener.com
These stocks are moving in today's after hours session - ChartMill
Corvus Capital's Activist Stake in CDT Equity (NASDAQ: CDT) Reaches 43.7% - kalkinemedia.com
Corvus Capital Converts CDT Equity (NASDAQ: CDT) Warrants into 5.44 Million Common Shares, Holding 43.7% Stake - Kalkine Media
Cdt equity CEO Andrew Regan’s entity acquires shares, disposes of 290 - Investing.com
Nearly 10% of CDT Equity Inc. (CDT) is reported in one shareholder group’s hands - Stock Titan
[Form 4] CDT Equity Inc. Insider Trading Activity - Stock Titan
[SCHEDULE 13D/A] CDT Equity Inc. Amended Major Shareholder Report - Stock Titan
CDT Equity Share Issuance Boosts Nasdaq Compliance Status - The Globe and Mail
Dow Surges Over 200 Points; Ollie's Bargain Outlet Shares Gain After Q2 Earnings - Benzinga
CDT Equity (NASDAQ: CDT) Achieves $23 Million Market Cap Following Full Warrant Conversion - Kalkine Media
CDT Equity Names James Bligh CEO Amid Leadership Shift - The Globe and Mail
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
CDT Equity Inc. Reports 13.7 Million Shares Outstanding and Nasdaq Compliance - Quiver Quantitative
CDT Provides Capital Update and Confirms No Nasdaq Deficiencies - The Manila Times
CDT Equity (CDT) Shares Fall 21% After Hours: Here's What Happened - Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
James Bligh Appointed CEO of CDT Equity (NASDAQ: CDT) Starting August 31 with $600,000 Salary - Kalkine Media
CDT Appoints Co-Founder James Bligh as Chief Executive Officer to Lead Next Phase of Growth - The Manila Times
CDT Equity appoints James Bligh as CEO; Andrew Regan resigns - TradingView
CDT Equity names CEO, gets reverse split approval - Stock Titan
CDT Equity Inc. Announces Resignation of Andrew Regan from the Board, Effective August 31, 2026 - marketscreener.com
CDT Validates Enhanced Solid-Form Properties within Its IP Portfolio - marketscreener.com
CDT Validates Enhanced Solid-Form Properties Within Its IP Portfolio - The Manila Times
CDT Equity Inc. Announces New Patent-Protected Solid Forms and AI-Identified Uses for Existing Drug Compounds - Moomoo
CDT's new drug-compound forms show improved stability and solubility - Stock Titan
CDT (CDT) Results Review: The Company Publishes Its Latest Results on the Day; Stock Move: The Stock Ends Down 18.32% in the Available RecordEarnings Beat Streak - dars.gov.et
Pep?d Inc. announced that it has received funding from CDT Equity Inc. - marketscreener.com
CDT Announces Investment in Pep'd, Expanding into the Fast-Growing US Peptide Market - The Manila Times
The global peptide therapeutics market is projected to reach $294.6B by 2033; CDT invests in Pep'd - Stock Titan
Enterprise value to revenue forward of CDT Equity Inc. – NASDAQ:CDTTW - TradingView
CDT (CDT) Chart: Falls 1.38% to $2.86 in Latest Trading; Immediate View: the Session Ends Within the Reported Technical Boundaries in the Available RecordMAMA Signal - vinanet.vn
Passive 2.97% stake by investor group in CDT Equity (CDT) - Stock Titan
New 5.3% passive stake surfaces in CDT Equity Inc. (CDT) - Stock Titan
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
CDT Equity (CDT) Sarborg losses, $65M patents and going‑concern doubts - Stock Titan
CDT | CDT Equity Inc. Common Executive Compensation - Quiver Quantitative
CDT Equity Inc. Q2 2026: Net loss $(4.64M), EPS $(8.71) — 10-Q Summary - TradingView
CDT Equity Inc. (CDT) flags going concern risk despite Sarborg investment gain - Stock Titan
CDT Equity Inc. Warrant (CDTTW) Holds Steady at $0.01 Amidst Quiet TradingRVOL Breakout - dars.gov.et
CDT Equity Inc. SEC Filing (Aug 11, 2026) - Stock Titan
CDT Equity Expands Convertible Note and Equity Financing - The Globe and Mail
CDT Equity Inc. (Nasdaq: CDT) lifts note to $2,536,650, adds warrants - Stock Titan
CDT Equity Inc. Revenue Breakdown – BOATS:CDTTW - TradingView
CDT Equity to Boost Stake in Sarborg - marketscreener.com
Press Release: CDT Increases Stake in Sarborg Following Its Quantum Computing and Intellectual Property Expansion - 富途牛牛
CDTTW Holds Steady at $0.01 as CDT Equity Warrant Trading Remains FlatIsland Reversal - vinanet.vn
Cdt Equity Inc (CDT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.30%
0.62%
자본화:
|
볼륨(24시간):